PSTV - Plus Therapeutics GAAP EPS of -$1.00 beats by $0.18 revenue of $1.24M beats by $0.08M
2023-10-31 16:11:19 ET
More on Plus Therapeutics
- Plus Therapeutics, Inc. (PSTV) Q2 2023 Earnings Call Transcript
- Biocept gains on licensing pact with Plus Therapeutics for cancer test
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Historical earnings data for Plus Therapeutics
- Financial information for Plus Therapeutics
For further details see:
Plus Therapeutics GAAP EPS of -$1.00 beats by $0.18, revenue of $1.24M beats by $0.08M